Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Completed 41Terminated 10Recruiting 8Unknown 6Not yet recruiting 2Active not recruiting 2Withdrawn 1No longer available 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2Gastrointestinal 2

Conditions

Leukemia, Myeloid, Chronic-Phase 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Gastrointestinal Stromal Tumors 2Rare Tumour 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Piebaldism 1

Interventions

Imatinib Mesylate 2regorafenib 1envafolimab 1Mastectomy, Segmental 1Endosonography 1Control Groups 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × Gastrointestinal Stromal Tumors × Imatinib Mesylate × Clear all
NCT07585266 2026-05-13

A Study to Investigate Velzatinib Compared With Imatinib in Adult Participants With Previously Untreated Metastatic and/or Unresectable Gastrointestinal Stromal Tumors (StrateGIST Frontline)

GlaxoSmithKline

Phase 3 Not yet recruiting
800 enrolled
GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT05970900 2023-08-01

PIRKER

Fujian Medical University Union Hospital

Phase 3 Not yet recruiting
23 enrolled
GastrointestinalSarcoma

Piebaldism, Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡